Merck - 48 Year Stock Price History | MRK

Historical daily share prices for Merck since 1970 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Merck as of August 16, 2018 is 68.85.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $179.189B $40.122B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $347.436B 16.60
Pfizer (PFE) United States $242.341B 14.19
Novartis AG (NVS) Switzerland $190.356B 16.33
AbbVie (ABBV) United States $145.249B 14.19
Novo Nordisk (NVO) Denmark $118.145B 18.89
Eli Lilly (LLY) United States $110.019B 20.37
Sanofi (SNY) France $103.584B 13.11
AstraZeneca (AZN) United Kingdom $98.732B 10.86
GlaxoSmithKline (GSK) United Kingdom $98.701B 13.18
Bristol-Myers Squibb (BMY) United States $98.007B 17.74